Since becoming a pure-play health tech group Philips has been buying like crazy. Might Siemens Healthineers and GE Healthcare join in?
Drug discovery is getting harder, and some companies are turning to machine learning to look for new targets.
Big pharma is using machine learning to improve the drug development process – but can the tech live up to the hype?
Sequencing data is all well and good, but what does it mean?
Boehringer gets diggi with it.
Philips prioritises artificial intelligence-based technologies as it seeks to grow its Connected Care and Health Informatics unit
Advances in computing power and machine learning could drastically change the way drugs are developed and paid for.